Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: 2017-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,374,579
- Percent of class
- 2.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-17-000166
- Form type
- SC 13G
- Filer
- Capital World Investors
- CIK
- CIK 1422849
- Filed
- Dec 11, 2017
- Reporting period
- Nov 30, 2017
- Description
- Schedule 13G beneficial ownership